FTC sues big pharmacy advantage managers around insulin price ranges The company brought action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of life-preserving insulin medications. Really don't skip tomorrow's healthcare field news Permit Healthcare Dive's free of charge https://kethek.com/